Gamma Gliadin IgA

If you suspect gluten is behind your symptoms, this is one of several blood antibodies you can check. It reflects whether your immune system is responding to a wheat protein, which is useful context but settles very little on its own.

A high result does not confirm celiac disease, and a normal result does not rule it out. That is exactly why this number matters most when read next to a few companion tests rather than in isolation.

What This Test Actually Measures

This test measures the amount of an IgA (immunoglobulin A) antibody that binds gamma-gliadin, one of the proteins that make up wheat gluten. Immunoglobulin A is one of the main antibody types your immune system produces, and your body makes this particular one after you eat gluten. A detectable level therefore means you have mounted an immune response to gluten, not that gluten is necessarily damaging you.

This is an IgA antibody, not the IgE antibody used in wheat allergy testing. The IgA form relates to gluten-driven gut immunity and celiac disease. IgE relates to immediate allergic reactions like hives or anaphylaxis. They are different tests answering different questions, so a result here says nothing about whether you have a classic wheat allergy.

Celiac Disease, the Main Reason It Is Ordered

In untreated celiac disease, gliadin antibodies including this one are often elevated. The catch is that antibodies against native gliadin are far less reliable than newer celiac tests, which is why guideline groups moved away from them. The preferred starting point today is an antibody against your own tissue transglutaminase (called tTG-IgA) measured alongside total IgA.

Sources: Rashtak et al. 2008 and Sugai et al. 2006 (native versus deamidated gliadin IgA); van der Windt et al. 2010 (native gliadin detection range); Gould et al. 2019 (isolated positivity in children). Note that most of these performance figures come from broader anti-gliadin or deamidated gliadin IgA assays, which are related to but not identical with a gamma-gliadin-specific IgA.

What this means for you: a positive gliadin IgA is a reason to keep investigating, not a diagnosis. The tTG-IgA test, by comparison, correctly flags roughly 93 of every 100 people with celiac disease and correctly clears about 98 of every 100 without it, so it does the heavy lifting.

Why an Isolated Positive Can Mislead

Gliadin IgA can appear before the disease-specific antibodies show up, and yet on its own it does not predict who will actually develop celiac disease. That is not a contradiction once you see the marker for what it is. It tracks gluten exposure and reactivity, not the autoimmune process that defines celiac disease. The disease-defining step is when antibodies against your own tissue transglutaminase appear, and until then a gliadin antibody by itself is a reactivity signal rather than a verdict.

Conditions Where the Link Is Weak or Uncertain

Some conditions get informally blamed on gluten antibodies with limited or conflicting support. In one case-control study of IgA nephropathy, a kidney disease, gliadin IgA was not meaningfully higher than in people without it, though other studies have reported elevated gliadin antibodies in this group, so the evidence is mixed rather than settled. In children with autism, IgA responses to gliadin did not differ from controls, although a subset showed higher IgG responses. The neurological picture is more complicated: one study of unexplained neuropathy and cerebellar ataxia found no difference in gliadin IgA from controls at standard cutoffs, but a meta-analysis reported that people with idiopathic cerebellar ataxia had roughly fourfold higher odds of testing positive for anti-gliadin antibodies, and gluten ataxia is a recognized entity, especially in relation to IgG anti-gliadin antibodies.

The practical takeaway is that a positive gliadin IgA is not enough on its own to diagnose these conditions, and its clearest meaning stays anchored to gluten reactivity and the celiac workup. For a suspected gluten-related neurological problem in particular, evaluation belongs with a specialist rather than resting on this single antibody.

Tracking It Over Time

A single reading tells you little, because the antibody rises and falls with what you eat and where you are in a disease process. The most useful reason to retest is to follow a gluten-free diet. Gliadin-peptide IgA antibodies drop substantially within 6 to 12 months of removing gluten, so a falling trend suggests your immune response to gluten is settling. This evidence comes from deamidated and gliadin-peptide IgA measurements, which are closely related to a gamma-gliadin-specific IgA.

A sensible rhythm is a baseline drawn while you are still eating gluten, a repeat a few months into any dietary change, and at least yearly if you are managing a gluten-related condition. One caution: antibody levels normalizing does not prove the gut lining has healed, so serology is a helpful trend, not a guarantee.

What to Do With an Unexpected Result

If this comes back positive or surprises you, the next move is not to self-diagnose or start a diet. Order the preferred first-line pair, tTG-IgA plus total IgA, and consider adding endomysial antibody (EMA-IgA) for confirmation. If your total IgA is low, IgA-based tests become unreliable and you switch to IgG-based versions such as tTG-IgG or deamidated gliadin peptide IgG.

A pattern of positive tTG-IgA together with positive EMA points strongly toward celiac disease and is worth a gastroenterology referral, usually for a duodenal biopsy. If only the gliadin IgA is positive while tTG and EMA are negative, celiac disease is unlikely, and watchful waiting or a specialist opinion is reasonable. Keep eating gluten until the workup is complete, or the results can turn falsely negative.

When a Reading Can Fool You

• IgA deficiency: a small share of people with celiac disease lack normal IgA, and if you are IgA deficient, every IgA-based test including this one can read falsely negative. This is why total IgA is measured alongside it.
• Already gluten-free: cutting gluten before testing lowers the antibody, so testing on a reduced-gluten diet can produce a false low and hide a real problem.
• Young children: in kids under about 4, an isolated positive gliadin or deamidated gliadin result is a common, often meaningless, transient finding.
• Assay differences: native gliadin and deamidated gliadin assays give different numbers, and labs vary, so results are not always interchangeable between tests.